BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8733128)

  • 1. Isolation of a new clathrin heavy chain gene with muscle-specific expression from the region commonly deleted in velo-cardio-facial syndrome.
    Sirotkin H; Morrow B; DasGupta R; Goldberg R; Patanjali SR; Shi G; Cannizzaro L; Shprintzen R; Weissman SM; Kucherlapati R
    Hum Mol Genet; 1996 May; 5(5):617-24. PubMed ID: 8733128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome.
    Sirotkin H; Morrow B; Saint-Jore B; Puech A; Das Gupta R; Patanjali SR; Skoultchi A; Weissman SM; Kucherlapati R
    Genomics; 1997 Jun; 42(2):245-51. PubMed ID: 9192844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the clathrin heavy chain-like gene (CLTCL) associated with features of DGS/VCFS: a balanced (21;22)(p12;q11) translocation.
    Holmes SE; Riazi MA; Gong W; McDermid HE; Sellinger BT; Hua A; Chen F; Wang Z; Zhang G; Roe B; Gonzalez I; McDonald-McGinn DM; Zackai E; Emanuel BS; Budarf ML
    Hum Mol Genet; 1997 Mar; 6(3):357-67. PubMed ID: 9147638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome.
    Sirotkin H; O'Donnell H; DasGupta R; Halford S; St Jore B; Puech A; Parimoo S; Morrow B; Skoultchi A; Weissman SM; Scambler P; Kucherlapati R
    Genomics; 1997 Apr; 41(1):75-83. PubMed ID: 9126485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
    Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
    Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183).
    Mulder MP; Wilke M; Langeveld A; Wilming LG; Hagemeijer A; van Drunen E; Zwarthoff EC; Riegman PH; Deelen WH; van den Ouweland AM
    Hum Genet; 1995 Aug; 96(2):133-41. PubMed ID: 7635459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11.
    Gong W; Emanuel BS; Collins J; Kim DH; Wang Z; Chen F; Zhang G; Roe B; Budarf ML
    Hum Mol Genet; 1996 Jun; 5(6):789-800. PubMed ID: 8776594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a novel gene containing WD40 repeats from the region deleted in velo-cardio-facial/DiGeorge syndrome on chromosome 22q11.
    Funke B; Pandita RK; Morrow BE
    Genomics; 2001 May; 73(3):264-71. PubMed ID: 11350118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a human gene containing a nuclear localization signal from the critical region for velo-cardio-facial syndrome on 22q11.
    Funke B; Puech A; Saint-Jore B; Pandita R; Skoultchi A; Morrow B
    Genomics; 1998 Oct; 53(2):146-54. PubMed ID: 9790763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit.
    Berti L; Mittler G; Przemeck GK; Stelzer G; Günzler B; Amati F; Conti E; Dallapiccola B; Hrabé de Angelis M; Novelli G; Meisterernst M
    Genomics; 2001 Jun; 74(3):320-32. PubMed ID: 11414760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess of deletions of maternal origin in the DiGeorge/velo-cardio-facial syndromes. A study of 22 new patients and review of the literature.
    Demczuk S; Lévy A; Aubry M; Croquette MF; Philip N; Prieur M; Sauer U; Bouvagnet P; Rouleau GA; Thomas G
    Hum Genet; 1995 Jul; 96(1):9-13. PubMed ID: 7607662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.
    Carlson C; Sirotkin H; Pandita R; Goldberg R; McKie J; Wadey R; Patanjali SR; Weissman SM; Anyane-Yeboa K; Warburton D; Scambler P; Shprintzen R; Kucherlapati R; Morrow BE
    Am J Hum Genet; 1997 Sep; 61(3):620-9. PubMed ID: 9326327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis. Molecular genetic study.
    Ivanov D; Kirov G; Norton N; Williams HJ; Williams NM; Nikolov I; Tzwetkova R; Stambolova SM; Murphy KC; Toncheva D; Thapar A; O'Donovan MC; Owen MJ
    Br J Psychiatry; 2003 Nov; 183():409-13. PubMed ID: 14594915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and characterization of the gene encoding human NPL4, a protein interacting with the ubiquitin fusion-degradation protein (UFD1L).
    Botta A; Tandoi C; Fini G; Calabrese G; Dallapiccola B; Novelli G
    Gene; 2001 Sep; 275(1):39-46. PubMed ID: 11574150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of a novel human clathrin heavy chain gene (CLTCL).
    Long KR; Trofatter JA; Ramesh V; McCormick MK; Buckler AJ
    Genomics; 1996 Aug; 35(3):466-72. PubMed ID: 8844170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and mutation analysis of goosecoid-like (GSCL), a homeodomain-containing gene that maps to the critical region for VCFS/DGS on 22q11.
    Funke B; Saint-Jore B; Puech A; Sirotkin H; Edelmann L; Carlson C; Raft S; Pandita RK; Kucherlapati R; Skoultchi A; Morrow BE
    Genomics; 1997 Dec; 46(3):364-72. PubMed ID: 9441739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects.
    Goldmuntz E; Driscoll D; Budarf ML; Zackai EH; McDonald-McGinn DM; Biegel JA; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):807-12. PubMed ID: 7901419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goosecoid-like (Gscl), a candidate gene for velocardiofacial syndrome, is not essential for normal mouse development.
    Saint-Jore B; Puech A; Heyer J; Lin Q; Raine C; Kucherlapati R; Skoultchi AI
    Hum Mol Genet; 1998 Nov; 7(12):1841-9. PubMed ID: 9811927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndrome.
    Halford S; Wilson DI; Daw SC; Roberts C; Wadey R; Kamath S; Wickremasinghe A; Burn J; Goodship J; Mattei MG
    Hum Mol Genet; 1993 Oct; 2(10):1577-82. PubMed ID: 8268909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects.
    Funke B; Epstein JA; Kochilas LK; Lu MM; Pandita RK; Liao J; Bauerndistel R; Schüler T; Schorle H; Brown MC; Adams J; Morrow BE
    Hum Mol Genet; 2001 Oct; 10(22):2549-56. PubMed ID: 11709542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.